Should "legal highs" be regulated as medicinal products?
Research output: Contribution to journal › Article › peer-review
Standard Standard
Should "legal highs" be regulated as medicinal products? / Evans-Brown, Michael; Bellis, Mark A; McVeigh, Jim.
In: BMJ-British Medical Journal, Vol. 342, 23.02.2011, p. d1101.
In: BMJ-British Medical Journal, Vol. 342, 23.02.2011, p. d1101.
Research output: Contribution to journal › Article › peer-review
HarvardHarvard
Evans-Brown, M, Bellis, MA & McVeigh, J 2011, 'Should "legal highs" be regulated as medicinal products?', BMJ-British Medical Journal, vol. 342, pp. d1101.
APA
Evans-Brown, M., Bellis, M. A., & McVeigh, J. (2011). Should "legal highs" be regulated as medicinal products? BMJ-British Medical Journal, 342, d1101.
CBE
Evans-Brown M, Bellis MA, McVeigh J. 2011. Should "legal highs" be regulated as medicinal products?. BMJ-British Medical Journal. 342:d1101.
MLA
Evans-Brown, Michael, Mark A Bellis and Jim McVeigh. "Should "legal highs" be regulated as medicinal products?". BMJ-British Medical Journal. 2011, 342. d1101.
VancouverVancouver
Evans-Brown M, Bellis MA, McVeigh J. Should "legal highs" be regulated as medicinal products? BMJ-British Medical Journal. 2011 Feb 23;342:d1101.
Author
RIS
TY - JOUR
T1 - Should "legal highs" be regulated as medicinal products?
AU - Evans-Brown, Michael
AU - Bellis, Mark A
AU - McVeigh, Jim
PY - 2011/2/23
Y1 - 2011/2/23
KW - Drug and Narcotic Control
KW - Psychotropic Drugs
KW - Street Drugs
KW - United Kingdom
KW - Journal Article
M3 - Article
C2 - 21345907
VL - 342
SP - d1101
JO - BMJ-British Medical Journal
JF - BMJ-British Medical Journal
SN - 1756-1833
ER -